GW 842470

Drug Profile

GW 842470

Alternative Names: 842470; AWD 12-281; GSK 842470; GW842470; GW842470X; GW842470X cream

Latest Information Update: 16 Jun 2011

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator elbion NV
  • Class Anti-inflammatories; Antiasthmatics
  • Mechanism of Action Type 4 cyclic nucleotide phosphodiesterase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Allergic rhinitis; Asthma; Atopic dermatitis; Chronic obstructive pulmonary disease

Most Recent Events

  • 15 Dec 2016 Biomarkers information updated
  • 05 Dec 2006 4AZA Bioscience has merged with elbion to form elbion NV
  • 22 Jun 2005 Phase-I clinical trials in Atopic dermatitis in Germany (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top